Boundless Bio, Inc. (BOLD)

NMS – Real vaqt narxi. Valyuta: USD

2.56

+0.05 (1.99%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

2.56

-0.00 (-0.05%)

Bozordan keyin: Jun 26, 2026, 7:53 PM EDT

Kompaniya haqida

Boundless Bio, Inc., klinik bosqichdagi onkologiya kompaniyasi, onkogen amplifikatsiyalangan saraton kasalligi bo'lgan bemorlarni davolash uchun ekstranuklear DNK (ecDNA) yo'naltirilgan terapiyalarni ishlab chiqadi. Uning yetakchi mahsulot nomzodi BBI-940 bo'lib, u ecDNA yo'naltirilgan terapevtik nomzod (ecDTx) bo'lib, estrogen retseptorlari ijobiy va inson epidermis o'sish omili retseptorlari 2-negativ ko'krak bezi saratoni, shuningdek, uch marta salbiy ko'krak bezi saratoni luminal androgen retseptorlari subtipi bo'lgan bemorlarda 1/2-faza klinik sinovida. Kompaniya ilgari Pretzel Therapeutics, Inc. nomi bilan tanilgan va 2019-yil iyul oyida Boundless Bio, Inc. nomini o'zgartirgan. Boundless Bio, Inc. 2018-yilda tashkil etilgan va San-Diego, Kaliforniyada joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. Christian Hassig Ph.D.	Chief Scientific Officer
Dr. Robert C. Doebele M.D., Ph.D.	Chief Medical Officer
Mr. David Hinkle	Senior VP of Finance, Controller & Corporate Treasurer
Mr. Zachary D. Hornby	CEO, President & Director
Ms. Amy Berkley Ph.D.	Senior Vice President of Program Team
Ms. Jessica Oien J.D.	Chief Legal Officer & Corporate Secretary